Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 17, 2025 09:00 ET | Source: NovalGen Ltd.

NovalGen to Begin World’s First Clinical Trial for a Self-Regulating Immunotherapy

Groundbreaking cancer therapy that self-inactivates when there is risk of toxicity approved by MHRA for entry into Phase I clinical trial
November 02, 2023 15:18 ET | Source: NovalGen Ltd.

NovalGen announces one oral and one poster presentation at the 65th American Society of Hematology Annual Meeting

NovalGen announces one oral and one poster presentation at the 65th American Society of Hematology Annual Meeting